What telehealth companies prescribe Ozempic?

Short answer: many general telehealth and specialty weight‑loss telemedicine providers will prescribe semaglutide (the active ingredient in Ozempic) when it’s medically appropriate. Which ones actually prescribe Ozempic specifically — versus another semaglutide brand such as Wegovy or a different GLP‑1 — depends on the company, the clinician, state laws, and your diagnosis.

Telehealth companies that commonly evaluate patients and (when appropriate) prescribe semaglutide/Ozempic

• Teladoc — large national telehealth network; primary‑care and specialty clinicians can treat diabetes/weight issues and prescribe medications when appropriate.
• Amwell — broad telemedicine platform used by many health systems; clinicians may prescribe semaglutide for qualifying patients.
• Doctor On Demand / Included Health — telehealth primary care/behavioral health with prescribing capability for chronic conditions.
• PlushCare — advertises diabetes and weight‑loss care and has prescribed GLP‑1s for eligible patients.
• Hims & Hers — runs telehealth weight‑loss programs and has offered semaglutide prescribing through clinician consultations.
• Ro (Roman) — offers primary‑care/weight programs and telehealth consults that have included GLP‑1 prescriptions.
• Calibrate — specialty weight‑loss program focused on metabolic care; integrates coaching with GLP‑1 prescribing for eligible patients.
• One Medical — membership primary care with telehealth visits; clinicians manage chronic disease and may prescribe semaglutide.
• Parsley Health — functional/holistic primary care that offers weight‑management programs and can prescr ibe GLP‑1s when indicated.
• GoodRx Care / HeyDoctor — telehealth consults tied to GoodRx that have facilitated semaglutide prescriptions in some cases.
• 98point6 and MDLive — text/video‑based primary care services that can prescribe non‑controlled meds, potentially including semaglutide.

Important caveats

• Prescribing is not guaranteed. Clinicians must evaluate your medical history, labs, and state law; many platforms will only prescribe for FDA‑approved indications (type 2 diabetes vs. obesity) or after appropriate screening.
• Some platforms prefer to prescribe the FDA‑approved weight‑loss product (Wegovy) rather than Ozempic; supply, insurance coverage, and cost vary widely. Off‑label use occurs but depends on the clinician.
• Expect baseline labs and follow‑up monitoring (kidney function, GI side effects, etc.) and discussion of contraindications.

What to do next

• Pick a platform available in your state, book an evaluation, and ask upfront whether they prescribe semaglutide/Ozempic (and whether they prescribe it for weight loss vs. diabetes).
• Ask about costs, whether they’ll prescribe Wegovy vs Ozempic, required labs/monitoring, and options if insurance won’t cover it.

If you want, tell me your state and whether you need Ozempic for diabetes or for weight loss and I can narrow which services are most likely to meet your needs.